<DOC>
	<DOCNO>NCT01286259</DOCNO>
	<brief_summary>The purpose study determine whether two-week course disulfiram reduce HIV-1 latent reservoir patient highly active antiretroviral therapy ( HAART ) .</brief_summary>
	<brief_title>Short-term Disulfiram Administration Accelerate Decay HIV Reservoir Antiretroviral-treated HIV Infected Individuals</brief_title>
	<detailed_description>This study use new approach try force HIV protect cellular reservoir . Although current therapy effective `` kill '' new virus produce , unable access virus cell infected antiretroviral therapy begin . HIV remain `` hidden '' latent ( rest ) form cell many year . Since infected cell live many year , think important barrier HIV eradication ( `` cure '' ) . Many expert believe one way attack latent `` hidden '' HIV use drug `` turn '' virus hence force HIV-1 resting T cell . In recent study do laboratory , disulfiram prove among effective drug currently available reactivate latent HIV-1 , Our primary hypothesis disulfiram reduce latent reservoir HIV-1 patient highly active antiretroviral therapy ( HAART ) . Theoretically , disulfiram force HIV replicate ( grow ) thus result death infect cell . Standard antiretroviral drug prevent new cell become infect . The end result process total amount HIV body decline time .</detailed_description>
	<mesh_term>Disulfiram</mesh_term>
	<criteria>Documented continuous HAART least 18 month prior study entry stable regimen least 3 month prior entry . Documented undetectable HIV viral load least one year . Intermittent isolate episode detectable lowlevel viremia `` blip '' ( &gt; 50 &lt; 500 copy RNA/mL ) remain eligible . Screening plasma HIV1 RNA level &lt; 40 copy RNA/mL . CD4 Tcell count 200 cells/uL 24 week prior screen . &gt; 90 % adherence therapy within precede 30 day . Females childbearing potential must negative serum pregnancy test screen agree use doublebarrier method contraception throughout study period . Willing abstain alcohol two week period disulfiram administer two week period immediately disulfiram administration . Current alcohol use disorder hazardous alcohol use determine clinical evaluation . Current use drug formulation contain alcohol might contain alcohol . Current use tipranavir . Current use maraviroc . Current use warfarin . Intending modify antiretroviral therapy next 27 week reason . Serious illness require hospitalization parental antibiotic within precede 3 month . Severe myocardial disease coronary artery disease . History psychosis . Clinically active hepatitis determine study physician ; ALT AST &gt; 3 x upper limit normal . Concurrent treatment immunomodulatory drug , exposure immunomodulatory drug past 16 week . Pregnant breastfeed woman .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>HIV</keyword>
	<keyword>HAART suppress</keyword>
	<keyword>Disulfiram</keyword>
	<keyword>Antabuse</keyword>
	<keyword>Latent reservoir</keyword>
	<keyword>Eradication</keyword>
	<keyword>Cure</keyword>
</DOC>